We’re Winning!

Thanks to the big 23% surge from Respironics (RESP), our Buy List has finally surpassed the market this year. For the year, we’re up 5.38% to the market’s 4.66%. Over the next few days, I’ll choose a replacement for Respironics for next year’s Buy List.

Posted by on December 21st, 2007 at 4:32 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.